You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Details for New Drug Application (NDA): 020235


✉ Email this page to a colleague

« Back to Dashboard


NDA 020235 describes NEURONTIN, which is a drug marketed by Viatris and is included in three NDAs. It is available from two suppliers. Additional details are available on the NEURONTIN profile page.

The generic ingredient in NEURONTIN is gabapentin. There are twenty-nine drug master file entries for this compound. Seventy-six suppliers are listed for this compound. Additional details are available on the gabapentin profile page.
Summary for 020235
Tradename:NEURONTIN
Applicant:Viatris
Ingredient:gabapentin
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 020235
Suppliers and Packaging for NDA: 020235
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NEURONTIN gabapentin CAPSULE;ORAL 020235 NDA Parke-Davis Div of Pfizer Inc 0071-0803 0071-0803-24 100 CAPSULE in 1 BOTTLE (0071-0803-24)
NEURONTIN gabapentin CAPSULE;ORAL 020235 NDA Parke-Davis Div of Pfizer Inc 0071-0805 0071-0805-24 100 CAPSULE in 1 BOTTLE (0071-0805-24)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength100MG
Approval Date:Dec 30, 1993TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength300MG
Approval Date:Dec 30, 1993TE:ABRLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength400MG
Approval Date:Dec 30, 1993TE:ABRLD:Yes

Expired US Patents for NDA 020235

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Viatris NEURONTIN gabapentin CAPSULE;ORAL 020235-003 Dec 30, 1993 ⤷  Try a Trial ⤷  Try a Trial
Viatris NEURONTIN gabapentin CAPSULE;ORAL 020235-001 Dec 30, 1993 ⤷  Try a Trial ⤷  Try a Trial
Viatris NEURONTIN gabapentin CAPSULE;ORAL 020235-003 Dec 30, 1993 ⤷  Try a Trial ⤷  Try a Trial
Viatris NEURONTIN gabapentin CAPSULE;ORAL 020235-003 Dec 30, 1993 ⤷  Try a Trial ⤷  Try a Trial
Viatris NEURONTIN gabapentin CAPSULE;ORAL 020235-002 Dec 30, 1993 ⤷  Try a Trial ⤷  Try a Trial
Viatris NEURONTIN gabapentin CAPSULE;ORAL 020235-002 Dec 30, 1993 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.